Table 1.
Guideline Author | Year of Issue | Acetaminophen | Opioid Analgesics | Peroral NSAIDs | SYSADOA | Topical NSAIDs | |
---|---|---|---|---|---|---|---|
Tramadol | Other | ||||||
AAOS | 2013 | Unable to give any recommendation | Positive recommendation | Inconclusive | Positive recommendation | Strong recommendation against use | Positive recommendation |
ACR/AF | 2020 | Conditional recommendation for | Conditional recommendation for | Conditional recommendation against | Recommended as first-line treatment | Strong recommendation against use | Strong recommendation for use prior to oral NSAIDs |
OARSI | 2019 | Conditional recommendation against | Strong recommendation against | Recommended as first-line treatment | Not included | Recommended as first-line treatment | |
ESCEO | 2019 | Weak recommendation against as single therapy, should be used as rescue medicine in addition to first-line treatment with SYSADOA | Conditional recommendation for as third-line treatment | Recommended as first-line, short-term treatment | Recommended as first-line, long-term treatment for pharmaceutical-grade products | Recommended in addition to SYSADOA and acetaminophen prior to oral NSAIDs |
AAOS—American Academy of Orthopedic Surgeons; ACR/AF—American College of Rheumatology/Arthritis Foundation; OARSI—Osteoarthritis Research Society International; ESCEO—European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases; NSAIDs—nonsteroidal anti-inflammatory drugs; SYSADOA—systemic slow-acting drugs in osteoarthritis.